Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care

Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care - Efficacy of rt-thrombomodulin for DIC in critical care

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006580

Enrollment

Registered

2011-10-24

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disseminated intravascular coagulation

Interventions

administration of recombinant thrombomodulin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as DIC

Exclusion criteria

Exclusion criteria: active bleeding

Design outcomes

Primary

Measure	Time frame
Laboratory data of DIC	—

Countries

Japan

Contacts

Public ContactKeiji Kumon

Nara Hospital, Kinki University School of Medicine Critical Care Medicine

kumon@nara.med.kindai.ac.jp0743-77-0880

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026